ReP USP - Resultado da busca

Artigo de periodico
Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo (2023)
Silvestre, Renata Nacasaki ; Eitler, Jiri; Azevedo, Júlia Teixeira Cottas de ; Tirapelle, Mariane Cariati; Fantacini, Daianne Maciely Carvalho ; Souza, Lucas Eduardo Botelho de ; Swiech, Kamilla ; Covas, Dimas Tadeu ; Calado, Rodrigo Tocantins ; Montero, Paola Ortiz; Malmegrim, Kelen Cristina Ribeiro ; Figueiredo, Marxa L.; Tonn, Torsten; Picanço-Castro, Virgínia
Source: Frontiers in Immunology. Unidades: FMRP, FCFRP
Subjects: ANTÍGENOS, LINHAGEM CELULAR, PROLIFERAÇÃO CELULAR, INTERLEUCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVESTRE, Renata Nacasaki et al. Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo. Frontiers in Immunology, v. 14, p. 1-15, 2023Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2023.1226518. Acesso em: 04 jun. 2024.
APA
Silvestre, R. N., Eitler, J., Azevedo, J. T. C. de, Tirapelle, M. C., Fantacini, D. M. C., Souza, L. E. B. de, et al. (2023). Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo. Frontiers in Immunology, 14, 1-15. doi:10.3389/fimmu.2023.1226518
NLM
Silvestre RN, Eitler J, Azevedo JTC de, Tirapelle MC, Fantacini DMC, Souza LEB de, Swiech K, Covas DT, Calado RT, Montero PO, Malmegrim KCR, Figueiredo ML, Tonn T, Picanço-Castro V. Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo [Internet]. Frontiers in Immunology. 2023 ; 14 1-15.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3389/fimmu.2023.1226518
Vancouver
Silvestre RN, Eitler J, Azevedo JTC de, Tirapelle MC, Fantacini DMC, Souza LEB de, Swiech K, Covas DT, Calado RT, Montero PO, Malmegrim KCR, Figueiredo ML, Tonn T, Picanço-Castro V. Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo [Internet]. Frontiers in Immunology. 2023 ; 14 1-15.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3389/fimmu.2023.1226518
Parte de monografia/livro
Expression systems for the production of therapeutic recombinant proteins (2022)
Mizukami, Amanda ; Pessoa Junior, Adalberto ; Swiech, Kamilla
Source: Pharmaceutical biotechnology: a focus on industrial application. Unidade: FCF
Subjects: PROTEÍNAS RECOMBINANTES, CÉLULAS VEGETAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIZUKAMI, Amanda e PESSOA JUNIOR, Adalberto e SWIECH, Kamilla. Expression systems for the production of therapeutic recombinant proteins. Pharmaceutical biotechnology: a focus on industrial application. Tradução . Boca Raton: CRC Press, 2022. . . Acesso em: 04 jun. 2024.
APA
Mizukami, A., Pessoa Junior, A., & Swiech, K. (2022). Expression systems for the production of therapeutic recombinant proteins. In Pharmaceutical biotechnology: a focus on industrial application. Boca Raton: CRC Press.
NLM
Mizukami A, Pessoa Junior A, Swiech K. Expression systems for the production of therapeutic recombinant proteins. In: Pharmaceutical biotechnology: a focus on industrial application. Boca Raton: CRC Press; 2022. [citado 2024 jun. 04 ]
Vancouver
Mizukami A, Pessoa Junior A, Swiech K. Expression systems for the production of therapeutic recombinant proteins. In: Pharmaceutical biotechnology: a focus on industrial application. Boca Raton: CRC Press; 2022. [citado 2024 jun. 04 ]
Artigo de periodico
Mesenchymal stromal cells in viral infections: implications for COVID-19 (2021)
Rocha, José Lucas Martins; Oliveira, Waldir César Ferreira de; Noronha, Nádia de Cássia ; Santos, Natalia Cristine Dias dos; Covas, Dimas Tadeu; Picanço-Castro, Virgínia; Swiech, Kamilla ; Farias, Kelen Cristina Ribeiro Malmegrim de
Source: Stem Cell Reviews and Reports. Unidades: FMRP, FCFRP
Subjects: CÉLULAS ESTROMAIS, COVID-19, ADJUVANTES IMUNOLÓGICOS, INSUFICIÊNCIA RESPIRATÓRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, José Lucas Martins et al. Mesenchymal stromal cells in viral infections: implications for COVID-19. Stem Cell Reviews and Reports, v. 17, n. 1, p. 71-93, 2021Tradução . . Disponível em: https://doi.org/10.1007/s12015-020-10032-7. Acesso em: 04 jun. 2024.
APA
Rocha, J. L. M., Oliveira, W. C. F. de, Noronha, N. de C., Santos, N. C. D. dos, Covas, D. T., Picanço-Castro, V., et al. (2021). Mesenchymal stromal cells in viral infections: implications for COVID-19. Stem Cell Reviews and Reports, 17( 1), 71-93. doi:10.1007/s12015-020-10032-7
NLM
Rocha JLM, Oliveira WCF de, Noronha N de C, Santos NCD dos, Covas DT, Picanço-Castro V, Swiech K, Farias KCRM de. Mesenchymal stromal cells in viral infections: implications for COVID-19 [Internet]. Stem Cell Reviews and Reports. 2021 ; 17( 1): 71-93.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1007/s12015-020-10032-7
Vancouver
Rocha JLM, Oliveira WCF de, Noronha N de C, Santos NCD dos, Covas DT, Picanço-Castro V, Swiech K, Farias KCRM de. Mesenchymal stromal cells in viral infections: implications for COVID-19 [Internet]. Stem Cell Reviews and Reports. 2021 ; 17( 1): 71-93.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1007/s12015-020-10032-7
Artigo de periodico
Generation of a three-dimensional in vitro ovarian cancer co-culture model for drug screening assays (2021)
Tofani, Larissa Bueno; Sousa, Lucas Oliveira ; Luiz, Marcela Tavares; Abriata, Juliana Palma; Marchetti, Juliana Maldonado; Leopoldino, Andréia Machado ; Swiech, Kamilla
Source: Journal of Pharmaceutical Sciences. Unidade: FCFRP
Subjects: LINHAGEM CELULAR, AVALIAÇÃO DE MEDICAMENTOS, NEOPLASIAS OVARIANAS, FARMACOTERAPIA, FIBROBLASTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOFANI, Larissa Bueno et al. Generation of a three-dimensional in vitro ovarian cancer co-culture model for drug screening assays. Journal of Pharmaceutical Sciences, v. 110, n. 7, p. 2629-2636, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.xphs.2021.04.003. Acesso em: 04 jun. 2024.
APA
Tofani, L. B., Sousa, L. O., Luiz, M. T., Abriata, J. P., Marchetti, J. M., Leopoldino, A. M., & Swiech, K. (2021). Generation of a three-dimensional in vitro ovarian cancer co-culture model for drug screening assays. Journal of Pharmaceutical Sciences, 110( 7), 2629-2636. doi:10.1016/j.xphs.2021.04.003
NLM
Tofani LB, Sousa LO, Luiz MT, Abriata JP, Marchetti JM, Leopoldino AM, Swiech K. Generation of a three-dimensional in vitro ovarian cancer co-culture model for drug screening assays [Internet]. Journal of Pharmaceutical Sciences. 2021 ; 110( 7): 2629-2636.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/j.xphs.2021.04.003
Vancouver
Tofani LB, Sousa LO, Luiz MT, Abriata JP, Marchetti JM, Leopoldino AM, Swiech K. Generation of a three-dimensional in vitro ovarian cancer co-culture model for drug screening assays [Internet]. Journal of Pharmaceutical Sciences. 2021 ; 110( 7): 2629-2636.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/j.xphs.2021.04.003
Artigo de periodico
Hypoxia priming improves in vitro angiogenic properties of umbilical cord derived-mesenchymal stromal cells expanded in stirred-tank bioreactor (2021)
Noronha, Nadia de Cássia; Mizukami, Amanda; Orellana, Maristela Delgado; Oliveira, Maria Carolina de; Covas, Dimas Tadeu; Swiech, Kamilla; Malmegrim, Kelen Cristina Ribeiro
Source: Biochemical Engineering Journal. Unidades: FMRP, FCFRP
Subjects: CÉLULAS ESTROMAIS, ANÓXIA, REATORES BIOQUÍMICOS, ADJUVANTES IMUNOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NORONHA, Nadia de Cássia et al. Hypoxia priming improves in vitro angiogenic properties of umbilical cord derived-mesenchymal stromal cells expanded in stirred-tank bioreactor. Biochemical Engineering Journal, v. 168, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bej.2021.107949. Acesso em: 04 jun. 2024.
APA
Noronha, N. de C., Mizukami, A., Orellana, M. D., Oliveira, M. C. de, Covas, D. T., Swiech, K., & Malmegrim, K. C. R. (2021). Hypoxia priming improves in vitro angiogenic properties of umbilical cord derived-mesenchymal stromal cells expanded in stirred-tank bioreactor. Biochemical Engineering Journal, 168, 1-11. doi:10.1016/j.bej.2021.107949
NLM
Noronha N de C, Mizukami A, Orellana MD, Oliveira MC de, Covas DT, Swiech K, Malmegrim KCR. Hypoxia priming improves in vitro angiogenic properties of umbilical cord derived-mesenchymal stromal cells expanded in stirred-tank bioreactor [Internet]. Biochemical Engineering Journal. 2021 ; 168 1-11.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/j.bej.2021.107949
Vancouver
Noronha N de C, Mizukami A, Orellana MD, Oliveira MC de, Covas DT, Swiech K, Malmegrim KCR. Hypoxia priming improves in vitro angiogenic properties of umbilical cord derived-mesenchymal stromal cells expanded in stirred-tank bioreactor [Internet]. Biochemical Engineering Journal. 2021 ; 168 1-11.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/j.bej.2021.107949
Monografia/livro-ed/org
Chimeric antigen receptor T Cells: development and production (2020)
Swiech, Kamilla (Editor) ; Malmegrim, Kelen Cristina Ribeiro (Editor) ; Picanço-Castro, Virgínia (Editor)
Unidades: FCFRP, FMRP
Subjects: IMUNOTERAPIA, ANTÍGENOS, BIOLOGIA MOLECULAR, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Chimeric antigen receptor T Cells: development and production. . New York: Humana Press. Disponível em: https://doi.org/10.1007/978-1-0716-0146-4. Acesso em: 04 jun. 2024. , 2020
APA
Chimeric antigen receptor T Cells: development and production. (2020). Chimeric antigen receptor T Cells: development and production. New York: Humana Press. doi:10.1007/978-1-0716-0146-4
NLM
Chimeric antigen receptor T Cells: development and production [Internet]. 2020 ;[citado 2024 jun. 04 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Vancouver
Chimeric antigen receptor T Cells: development and production [Internet]. 2020 ;[citado 2024 jun. 04 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Monografia/livro-ed/org
Chimeric antigen receptor T Cell: development and production (2020)
Swiech, Kamilla (Editor) ; Malmegrim, Kelen Cristina Ribeiro (Editor) ; Picanço-Castro, Virgínia (Editor)
Unidades: FCFRP, FMRP
Subjects: IMUNOTERAPIA, RECEPTORES DE ANTÍGENOS, ANTÍGENOS, LINHAGEM CELULAR, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Chimeric antigen receptor T Cell: development and production. . New York: Humana Press. Disponível em: https://doi.org/10.1007/978-1-0716-0146-4. Acesso em: 04 jun. 2024. , 2020
APA
Chimeric antigen receptor T Cell: development and production. (2020). Chimeric antigen receptor T Cell: development and production. New York: Humana Press. doi:10.1007/978-1-0716-0146-4
NLM
Chimeric antigen receptor T Cell: development and production [Internet]. 2020 ;[citado 2024 jun. 04 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Vancouver
Chimeric antigen receptor T Cell: development and production [Internet]. 2020 ;[citado 2024 jun. 04 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Parte de monografia/livro-apres/pref/posf
Immunotherapy is a treatment that boosts the body’s natural defenses to fight cancer. [Prefácio] (2020)
Swiech, Kamilla ; Malmegrim, Kelen Cristina Ribeiro ; Picanço-Castro, Virgínia
Source: Chimeric antigen receptor T Cell: development and production. Unidades: FCFRP, FMRP
Subjects: IMUNOTERAPIA, ANTÍGENOS, RECEPTORES DE ANTÍGENOS, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SWIECH, Kamilla e MALMEGRIM, Kelen Cristina Ribeiro e PICANÇO-CASTRO, Virgínia. Immunotherapy is a treatment that boosts the body’s natural defenses to fight cancer. [Prefácio]. Chimeric antigen receptor T Cell: development and production. New York: Humana Press. Disponível em: https://doi.org/10.1007/978-1-0716-0146-4. Acesso em: 04 jun. 2024. , 2020
APA
Swiech, K., Malmegrim, K. C. R., & Picanço-Castro, V. (2020). Immunotherapy is a treatment that boosts the body’s natural defenses to fight cancer. [Prefácio]. Chimeric antigen receptor T Cell: development and production. New York: Humana Press. doi:10.1007/978-1-0716-0146-4
NLM
Swiech K, Malmegrim KCR, Picanço-Castro V. Immunotherapy is a treatment that boosts the body’s natural defenses to fight cancer. [Prefácio] [Internet]. Chimeric antigen receptor T Cell: development and production. 2020 ;274 .[citado 2024 jun. 04 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Vancouver
Swiech K, Malmegrim KCR, Picanço-Castro V. Immunotherapy is a treatment that boosts the body’s natural defenses to fight cancer. [Prefácio] [Internet]. Chimeric antigen receptor T Cell: development and production. 2020 ;274 .[citado 2024 jun. 04 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Artigo de periodico
Feasibility of the taylor vortex flow bioreactor for mesenchymal stromal cell expansion on microcarriers (2020)
Gonzalez Gil, Liseth Viviana; Singh, Harminder; Silva, Juliana de Sá da; Santos, Diogo Peres dos; Covas, Dimas Tadeu ; Swiech, Kamilla ; Torres Suazo, Claudio Alberto
Source: Biochemical Engineering Journal. Unidades: FMRP, FCFRP
Subjects: CÉLULAS ESTROMAIS, ENGENHARIA QUÍMICA, MEDICINA REGENERATIVA, REATORES BIOQUÍMICOS, CULTURA DE CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONZALEZ GIL, Liseth Viviana et al. Feasibility of the taylor vortex flow bioreactor for mesenchymal stromal cell expansion on microcarriers. Biochemical Engineering Journal, v. 162, p. 1-11, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bej.2020.107710. Acesso em: 04 jun. 2024.
APA
Gonzalez Gil, L. V., Singh, H., Silva, J. de S. da, Santos, D. P. dos, Covas, D. T., Swiech, K., & Torres Suazo, C. A. (2020). Feasibility of the taylor vortex flow bioreactor for mesenchymal stromal cell expansion on microcarriers. Biochemical Engineering Journal, 162, 1-11. doi:10.1016/j.bej.2020.107710
NLM
Gonzalez Gil LV, Singh H, Silva J de S da, Santos DP dos, Covas DT, Swiech K, Torres Suazo CA. Feasibility of the taylor vortex flow bioreactor for mesenchymal stromal cell expansion on microcarriers [Internet]. Biochemical Engineering Journal. 2020 ; 162 1-11.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/j.bej.2020.107710
Vancouver
Gonzalez Gil LV, Singh H, Silva J de S da, Santos DP dos, Covas DT, Swiech K, Torres Suazo CA. Feasibility of the taylor vortex flow bioreactor for mesenchymal stromal cell expansion on microcarriers [Internet]. Biochemical Engineering Journal. 2020 ; 162 1-11.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/j.bej.2020.107710
Artigo de periodico
Mesenchymal stromal cells maintain the major quality attributes when expanded in different bioreactor systems (2020)
Silva, Juliana de Sá da; Severino, Patricia; Wodewotzky, Thaila Isabel; Covas, Dimas Tadeu ; Swiech, Kamilla ; Marti, Luciana Cavalheiro; Suazo, Claudio Alberto Torres
Source: Biochemical Engineering Journal. Unidades: FMRP, FCFRP
Subjects: CÉLULAS ESTROMAIS, REATORES BIOQUÍMICOS, EXPRESSÃO GÊNICA, BIOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Juliana de Sá da et al. Mesenchymal stromal cells maintain the major quality attributes when expanded in different bioreactor systems. Biochemical Engineering Journal, v. 161, p. 1-9, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bej.2020.107693. Acesso em: 04 jun. 2024.
APA
Silva, J. de S. da, Severino, P., Wodewotzky, T. I., Covas, D. T., Swiech, K., Marti, L. C., & Suazo, C. A. T. (2020). Mesenchymal stromal cells maintain the major quality attributes when expanded in different bioreactor systems. Biochemical Engineering Journal, 161, 1-9. doi:10.1016/j.bej.2020.107693
NLM
Silva J de S da, Severino P, Wodewotzky TI, Covas DT, Swiech K, Marti LC, Suazo CAT. Mesenchymal stromal cells maintain the major quality attributes when expanded in different bioreactor systems [Internet]. Biochemical Engineering Journal. 2020 ; 161 1-9.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/j.bej.2020.107693
Vancouver
Silva J de S da, Severino P, Wodewotzky TI, Covas DT, Swiech K, Marti LC, Suazo CAT. Mesenchymal stromal cells maintain the major quality attributes when expanded in different bioreactor systems [Internet]. Biochemical Engineering Journal. 2020 ; 161 1-9.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/j.bej.2020.107693
Parte de monografia/livro
Platforms for clinical-grade CAR-T cell expansion (2020)
Mizukami, Amanda ; Swiech, Kamilla
Source: Chimeric antigen receptor T Cell: development and production. Unidades: FCFRP, FMRP
Subjects: LENTIVIRUS, RECEPTORES DE ANTÍGENOS, ANTÍGENOS, IMUNOTERAPIA, CONTROLE DA QUALIDADE, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIZUKAMI, Amanda e SWIECH, Kamilla. Platforms for clinical-grade CAR-T cell expansion. Chimeric antigen receptor T Cell: development and production. Tradução . New York: Humana Press, 2020. p. 274 . Disponível em: https://doi.org/10.1007/978-1-0716-0146-4. Acesso em: 04 jun. 2024.
APA
Mizukami, A., & Swiech, K. (2020). Platforms for clinical-grade CAR-T cell expansion. In Chimeric antigen receptor T Cell: development and production (p. 274 ). New York: Humana Press. doi:10.1007/978-1-0716-0146-4
NLM
Mizukami A, Swiech K. Platforms for clinical-grade CAR-T cell expansion [Internet]. In: Chimeric antigen receptor T Cell: development and production. New York: Humana Press; 2020. p. 274 .[citado 2024 jun. 04 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Vancouver
Mizukami A, Swiech K. Platforms for clinical-grade CAR-T cell expansion [Internet]. In: Chimeric antigen receptor T Cell: development and production. New York: Humana Press; 2020. p. 274 .[citado 2024 jun. 04 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Trabalho de evento-resumo periodico
Non-viral engineering of CAR-NK cells for cancer immunotherapy (2020)
Gomes, Kauan Ribeiro de Sena; Silvestre, Renata Nacasaki; Azevedo, Júlia Teixeira Cottas de; Swiech, Kamilla ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Covas, Dimas Tadeu; Picanço-Castro, Virgínia
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HemoPlay 2020). Unidades: FCFRP, FMRP
Subjects: LINFÓCITOS, CÉLULAS, IMUNOTERAPIA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Kauan Ribeiro de Sena et al. Non-viral engineering of CAR-NK cells for cancer immunotherapy. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.706. Acesso em: 04 jun. 2024. , 2020
APA
Gomes, K. R. de S., Silvestre, R. N., Azevedo, J. T. C. de, Swiech, K., Farias, K. C. R. M. de, Covas, D. T., & Picanço-Castro, V. (2020). Non-viral engineering of CAR-NK cells for cancer immunotherapy. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.706
NLM
Gomes KR de S, Silvestre RN, Azevedo JTC de, Swiech K, Farias KCRM de, Covas DT, Picanço-Castro V. Non-viral engineering of CAR-NK cells for cancer immunotherapy [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S420.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/j.htct.2020.10.706
Vancouver
Gomes KR de S, Silvestre RN, Azevedo JTC de, Swiech K, Farias KCRM de, Covas DT, Picanço-Castro V. Non-viral engineering of CAR-NK cells for cancer immunotherapy [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S420.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/j.htct.2020.10.706
Trabalho de evento-resumo periodico
Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment (2020)
Silvestre, Renata Nacasaki; Eitler, J.; Fantacini, Daianne Maciely Carvalho ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Swiech, Kamilla ; Covas, Dimas Tadeu; Tonn, T.; Picanço-Castro, Virgínia
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HemoPlay 2020). Unidades: FCFRP, FMRP
Subjects: LEUCEMIA, LINFOMA, LINFÓCITOS B, LINFÓCITOS T
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVESTRE, Renata Nacasaki et al. Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.703. Acesso em: 04 jun. 2024. , 2020
APA
Silvestre, R. N., Eitler, J., Fantacini, D. M. C., Farias, K. C. R. M. de, Swiech, K., Covas, D. T., et al. (2020). Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.703
NLM
Silvestre RN, Eitler J, Fantacini DMC, Farias KCRM de, Swiech K, Covas DT, Tonn T, Picanço-Castro V. Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S418.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/j.htct.2020.10.703
Vancouver
Silvestre RN, Eitler J, Fantacini DMC, Farias KCRM de, Swiech K, Covas DT, Tonn T, Picanço-Castro V. Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S418.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/j.htct.2020.10.703
Artigo de periodico
Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays (2020)
Tofani, Larissa Bueno ; Abriata, Juliana Palma ; Luiz, Marcela Tavares ; Marchetti, Juliana Maldonado ; Swiech, Kamilla
Source: Biotechnology Progress. Unidade: FCFRP
Subjects: NEOPLASIAS OVARIANAS, FÁRMACOS, BIOTECNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOFANI, Larissa Bueno et al. Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays. Biotechnology Progress, v. 36, n. 6, p. 1-11, 2020Tradução . . Disponível em: https://doi.org/10.1002/btpr.3034. Acesso em: 04 jun. 2024.
APA
Tofani, L. B., Abriata, J. P., Luiz, M. T., Marchetti, J. M., & Swiech, K. (2020). Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays. Biotechnology Progress, 36( 6), 1-11. doi:10.1002/btpr.3034
NLM
Tofani LB, Abriata JP, Luiz MT, Marchetti JM, Swiech K. Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays [Internet]. Biotechnology Progress. 2020 ; 36( 6): 1-11.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1002/btpr.3034
Vancouver
Tofani LB, Abriata JP, Luiz MT, Marchetti JM, Swiech K. Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays [Internet]. Biotechnology Progress. 2020 ; 36( 6): 1-11.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1002/btpr.3034
Artigo de periodico
A simple three-dimensional in vitro culture mimicking the in vivo-like cell behavior of bladder patient-derived xenograft models (2020)
Amaral, Robson Luis Ferraz do; Zimmermann, Maike; Ma, Ai-Hong; Zhang, Hongyong; Swiech, Kamilla ; Pan, Chong-Xian
Source: Cancers. Unidade: FCFRP
Subjects: ANTINEOPLÁSICOS, FENÓTIPOS, NEOPLASIAS DA BEXIGA, MATRIZ EXTRACELULAR, CULTURA DE CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMARAL, Robson Luis Ferraz do et al. A simple three-dimensional in vitro culture mimicking the in vivo-like cell behavior of bladder patient-derived xenograft models. Cancers, v. 12, n. 5, p. 1-13, 2020Tradução . . Disponível em: https://doi.org/10.3390/cancers12051304. Acesso em: 04 jun. 2024.
APA
Amaral, R. L. F. do, Zimmermann, M., Ma, A. -H., Zhang, H., Swiech, K., & Pan, C. -X. (2020). A simple three-dimensional in vitro culture mimicking the in vivo-like cell behavior of bladder patient-derived xenograft models. Cancers, 12( 5), 1-13. doi:10.3390/cancers12051304
NLM
Amaral RLF do, Zimmermann M, Ma A-H, Zhang H, Swiech K, Pan C-X. A simple three-dimensional in vitro culture mimicking the in vivo-like cell behavior of bladder patient-derived xenograft models [Internet]. Cancers. 2020 ; 12( 5): 1-13.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3390/cancers12051304
Vancouver
Amaral RLF do, Zimmermann M, Ma A-H, Zhang H, Swiech K, Pan C-X. A simple three-dimensional in vitro culture mimicking the in vivo-like cell behavior of bladder patient-derived xenograft models [Internet]. Cancers. 2020 ; 12( 5): 1-13.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3390/cancers12051304
Artigo de periodico
Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies (2020)
Picanço-Castro, Virgínia; Moço, Pablo Diego; Mizukami, Amanda; Vaz, Leticia Delfini; Pereira, Marcelo de Souza Fernandes; Silvestre, Renata Nacasaki; Azevedo, Júlia Teixeira Cottas de; Bomfim, Aline de Sousa; Abreu-Neto, Mário Soares de; Farias, Kelen Cristina Ribeiro Malmegrim de ; Swiech, Kamilla ; Covas, Dimas Tadeu
Source: Hematology, Transfusion and Cell Therapy. Unidades: FCFRP, FMRP
Subjects: HEMATOLOGIA, CITOTOXICIDADE IMUNOLÓGICA, IMUNOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PICANÇO-CASTRO, Virgínia et al. Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies. Hematology, Transfusion and Cell Therapy, v. 42, n. 2, p. 150-158, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2019.06.007. Acesso em: 04 jun. 2024.
APA
Picanço-Castro, V., Moço, P. D., Mizukami, A., Vaz, L. D., Pereira, M. de S. F., Silvestre, R. N., et al. (2020). Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies. Hematology, Transfusion and Cell Therapy, 42( 2), 150-158. doi:10.1016/j.htct.2019.06.007
NLM
Picanço-Castro V, Moço PD, Mizukami A, Vaz LD, Pereira M de SF, Silvestre RN, Azevedo JTC de, Bomfim A de S, Abreu-Neto MS de, Farias KCRM de, Swiech K, Covas DT. Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42( 2): 150-158.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/j.htct.2019.06.007
Vancouver
Picanço-Castro V, Moço PD, Mizukami A, Vaz LD, Pereira M de SF, Silvestre RN, Azevedo JTC de, Bomfim A de S, Abreu-Neto MS de, Farias KCRM de, Swiech K, Covas DT. Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42( 2): 150-158.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/j.htct.2019.06.007
Trabalho de evento-resumo periodico
Hypoxia and 3D combined priming improves in vitro Paracrine angiogenic potential of UC-MSC (2020)
Noronha, Nádia de Cássia ; Mizukami, Amanda ; Orellana, M. D.; Covas, Dimas Tadeu ; Swiech, Kamilla ; Farias, Kelen Cristina Ribeiro Malmegrim de
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular - HemoPlay. Unidades: FMRP, FCFRP
Subjects: ANÓXIA, CÉLULAS ESTROMAIS, ADJUVANTES IMUNOLÓGICOS, HOMEOSTASE, DOENÇAS IMUNOLÓGICAS, DOENÇAS DEGENERATIVAS, SOBREVIVÊNCIA CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NORONHA, Nádia de Cássia et al. Hypoxia and 3D combined priming improves in vitro Paracrine angiogenic potential of UC-MSC. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.705. Acesso em: 04 jun. 2024. , 2020
APA
Noronha, N. de C., Mizukami, A., Orellana, M. D., Covas, D. T., Swiech, K., & Farias, K. C. R. M. de. (2020). Hypoxia and 3D combined priming improves in vitro Paracrine angiogenic potential of UC-MSC. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.705
NLM
Noronha N de C, Mizukami A, Orellana MD, Covas DT, Swiech K, Farias KCRM de. Hypoxia and 3D combined priming improves in vitro Paracrine angiogenic potential of UC-MSC [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S419.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/j.htct.2020.10.705
Vancouver
Noronha N de C, Mizukami A, Orellana MD, Covas DT, Swiech K, Farias KCRM de. Hypoxia and 3D combined priming improves in vitro Paracrine angiogenic potential of UC-MSC [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S419.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/j.htct.2020.10.705
Artigo de periodico
Emerging CAR T cell therapies: clinical landscape and patent technological routes (2020)
Picanço-Castro, Virgínia; Pereira, Cristiano Gonçalves; Swiech, Kamilla ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Covas, Dimas Tadeu; Porto, Geciane Silveira
Source: Human Vaccines & Immunotherapeutics. Unidades: FMRP, FCFRP, FEARP
Subjects: PATENTE, TECNOLOGIA, CÉLULAS, TESTES LABORATORIAIS, INOVAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PICANÇO-CASTRO, Virgínia et al. Emerging CAR T cell therapies: clinical landscape and patent technological routes. Human Vaccines & Immunotherapeutics, v. 16, n. 6, p. 1424–1433, 2020Tradução . . Disponível em: https://doi.org/10.1080/21645515.2019.1689744. Acesso em: 04 jun. 2024.
APA
Picanço-Castro, V., Pereira, C. G., Swiech, K., Farias, K. C. R. M. de, Covas, D. T., & Porto, G. S. (2020). Emerging CAR T cell therapies: clinical landscape and patent technological routes. Human Vaccines & Immunotherapeutics, 16( 6), 1424–1433. doi:10.1080/21645515.2019.1689744
NLM
Picanço-Castro V, Pereira CG, Swiech K, Farias KCRM de, Covas DT, Porto GS. Emerging CAR T cell therapies: clinical landscape and patent technological routes [Internet]. Human Vaccines & Immunotherapeutics. 2020 ; 16( 6): 1424–1433.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1080/21645515.2019.1689744
Vancouver
Picanço-Castro V, Pereira CG, Swiech K, Farias KCRM de, Covas DT, Porto GS. Emerging CAR T cell therapies: clinical landscape and patent technological routes [Internet]. Human Vaccines & Immunotherapeutics. 2020 ; 16( 6): 1424–1433.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1080/21645515.2019.1689744
Artigo de periodico
Successful use of human AB serum to support the expansion of adipose tissue-derived mesenchymal stem/stromal cell in a microcarrier-based platform (2020)
Moreira, Francisco; Mizukami, Amanda ; Souza, Lucas Eduardo Botelho de ; Cabral, Joaquim M. S.; Silva, Cláudia L. da; Covas, Dimas Tadeu ; Swiech, Kamilla
Source: Frontiers in Bioengineering and Biotechnology. Unidades: FMRP, FCFRP
Subjects: TECIDO ADIPOSO, CÉLULAS-TRONCO, MESODERMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, Francisco et al. Successful use of human AB serum to support the expansion of adipose tissue-derived mesenchymal stem/stromal cell in a microcarrier-based platform. Frontiers in Bioengineering and Biotechnology, v. 8, p. 1-9, 2020Tradução . . Disponível em: https://doi.org/10.3389/fbioe.2020.00307. Acesso em: 04 jun. 2024.
APA
Moreira, F., Mizukami, A., Souza, L. E. B. de, Cabral, J. M. S., Silva, C. L. da, Covas, D. T., & Swiech, K. (2020). Successful use of human AB serum to support the expansion of adipose tissue-derived mesenchymal stem/stromal cell in a microcarrier-based platform. Frontiers in Bioengineering and Biotechnology, 8, 1-9. doi:10.3389/fbioe.2020.00307
NLM
Moreira F, Mizukami A, Souza LEB de, Cabral JMS, Silva CL da, Covas DT, Swiech K. Successful use of human AB serum to support the expansion of adipose tissue-derived mesenchymal stem/stromal cell in a microcarrier-based platform [Internet]. Frontiers in Bioengineering and Biotechnology. 2020 ; 8 1-9.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3389/fbioe.2020.00307
Vancouver
Moreira F, Mizukami A, Souza LEB de, Cabral JMS, Silva CL da, Covas DT, Swiech K. Successful use of human AB serum to support the expansion of adipose tissue-derived mesenchymal stem/stromal cell in a microcarrier-based platform [Internet]. Frontiers in Bioengineering and Biotechnology. 2020 ; 8 1-9.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3389/fbioe.2020.00307
Parte de monografia/livro
CAR-T cells for cancer treatment: current design and next frontiers (2020)
Picanço-Castro, Virgínia; Swiech, Kamilla ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Covas, Dimas Tadeu
Source: Chimeric Antigen Receptor T Cell: Development and Production. Unidades: FCFRP, FMRP
Subjects: IMUNOTERAPIA, NEOPLASIAS, IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PICANÇO-CASTRO, Virgínia et al. CAR-T cells for cancer treatment: current design and next frontiers. Chimeric Antigen Receptor T Cell: Development and Production. Tradução . New York: Humana Press, 2020. . Disponível em: https://doi.org/10.1007/978-1-0716-0146-4_1. Acesso em: 04 jun. 2024.
APA
Picanço-Castro, V., Swiech, K., Farias, K. C. R. M. de, & Covas, D. T. (2020). CAR-T cells for cancer treatment: current design and next frontiers. In Chimeric Antigen Receptor T Cell: Development and Production. New York: Humana Press. doi:10.1007/978-1-0716-0146-4_1
NLM
Picanço-Castro V, Swiech K, Farias KCRM de, Covas DT. CAR-T cells for cancer treatment: current design and next frontiers [Internet]. In: Chimeric Antigen Receptor T Cell: Development and Production. New York: Humana Press; 2020. [citado 2024 jun. 04 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4_1
Vancouver
Picanço-Castro V, Swiech K, Farias KCRM de, Covas DT. CAR-T cells for cancer treatment: current design and next frontiers [Internet]. In: Chimeric Antigen Receptor T Cell: Development and Production. New York: Humana Press; 2020. [citado 2024 jun. 04 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4_1

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration